|
⚲
|
| Keyboard |
| Bazarko Daniel
✚
|
|
|---|---|
| CIK # | 0001768214 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001768214] | |
| 4 | [0001768214] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Alexion Pharmaceuticals Inc | |
| Bazarko Daniel |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2021-07-21 | Disposed to issuer | 60,207 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Option to Purchase Common Stock · derivative
|
2021-07-21 | Disposed to issuer | 5,111 | $176.80 | 903,625 |
|
Alexion Pharmaceuticals Inc ALXN
Option to Purchase Common Stock · derivative
|
2021-07-21 | Disposed to issuer | 3,943 | $180.37 | 711,199 |
|
Alexion Pharmaceuticals Inc ALXN
Option to Purchase Common Stock · derivative
|
2021-07-21 | Disposed to issuer | 2,912 | $180.28 | 524,975 |
|
Alexion Pharmaceuticals Inc ALXN
Option to Purchase Common Stock · derivative
|
2021-07-21 | Disposed to issuer | 5,300 | $131.25 | 695,625 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2021-07-14 | Grant | 11,060 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2021-07-14 | Grant | 10,648 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2021-02-28 | Grant | 7,616 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2020-12-17 | Sell | 9,900 | $157.59 | 1,560,141 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2020-12-17 | Sell | 1,100 | $158.00 | 173,800 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2020-12-17 | Option exercise | 11,000 | $140.16 | 1,541,760 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2020-12-17 | Option exercise | 13,066 | $97.58 | 1,274,980 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2020-12-17 | Sell | 13,066 | $157.76 | 2,061,292 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock · derivative
|
2020-12-17 | Option exercise | 13,066 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock · derivative
|
2020-12-17 | Option exercise | 11,000 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2020-12-16 | Grant | 15,371 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2020-12-16 | Tax withheld | 1,725 | $157.96 | 272,481 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2020-12-16 | Tax withheld | 7,087 | $157.96 | 1,119,463 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2020-03-02 | Tax withheld | 886 | $90.53 | 80,210 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2020-02-28 | Grant | 3,927 | $0.00 | |
| showing 20 of 29 most recent transactions | |||||